AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 10 | -99.9% | 0.00% | – |
| Q1 2022 | $101,000 | -61.5% | 10,690 | -52.8% | 0.00% | – |
| Q4 2021 | $262,000 | +26100.0% | 22,646 | +36425.8% | 0.00% | – |
| Q3 2021 | $1,000 | -96.3% | 62 | -97.8% | 0.00% | – |
| Q2 2021 | $27,000 | – | 2,777 | +27670.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
| Q4 2020 | $31,186,000 | +4195.6% | 1,350,610 | +2528.2% | 0.05% | +4600.0% |
| Q3 2020 | $726,000 | -87.5% | 51,390 | -86.7% | 0.00% | -91.7% |
| Q2 2020 | $5,821,000 | -34.1% | 386,000 | -45.4% | 0.01% | -33.3% |
| Q2 2019 | $8,831,000 | +174.0% | 707,600 | +165.4% | 0.02% | +200.0% |
| Q3 2018 | $3,223,000 | +2437.8% | 266,600 | +2015.9% | 0.01% | – |
| Q2 2017 | $127,000 | -98.3% | 12,600 | -98.8% | 0.00% | -100.0% |
| Q1 2017 | $7,346,000 | +34881.0% | 1,030,300 | +10101.0% | 0.02% | – |
| Q1 2014 | $21,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |